Edition:
United States

Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

4.82USD
23 Aug 2017
Change (% chg)

-- (--)
Prev Close
$4.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,752,500
52-wk High
$9.49
52-wk Low
$3.15

SIMON NICHOLAS J III

Institutional Holders

% Shares Owned: 96.10%
# of Holders: 198
Total Shares Held: 131,425,154
3 Mo. Net Change: 4,008,884
# New Positions: 22
# Closed Positions: 20
# Increased Positions: 72
# Reduced Positions: 81
# Net Buyers: -9

Officers & Directors

Name Age Since Current Position

David Scheer

63 2010 Chairman of the Board

Milind Deshpande

59 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2015 Chief Financial Officer, Executive Vice President

Martha Manning

61 2016 Executive Vice President, General Counsel, Corporate Secretary

David Apelian

51 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

51 2014 Executive Vice President, Chief Commercial Officer

Amy Jennings

2016 Senior Vice President - Regulatory Affairs

Michael Kishbauch

67 2013 Director

Frank Verwiel

55 2015 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

49 2012 Independent Director

Robert Van Nostrand

60 2007 Independent Director

Nicole Vitullo

59 2010 Independent Director